About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ptgestm1Lpa
targeted mutation 1, Laurent P Audoly
MGI:3045658
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ptgestm1Lpa/Ptgestm1Lpa DBA/1LacJ-Ptgestm1Lpa MGI:3045812


Genotype
MGI:3045812
hm1
Allelic
Composition
Ptgestm1Lpa/Ptgestm1Lpa
Genetic
Background
DBA/1LacJ-Ptgestm1Lpa
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptgestm1Lpa mutation (0 available); any Ptges mutation (47 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• the inflammatory pain response is decreased in mutants and is similar to wild-type mice treated with an NSAID

immune system
• mutants have a smaller increase in prostaglandin E2 production following treatment with arachidonic acid compared to wild-type mice (J:89960)
• mutants do not have increased prostaglandin E2 production following treatment with lipopolysaccharide (J:89960)
• following antigen injection mutants do not develop edema and have fewer white blood cells infiltrating the injection site (J:89960)
• following immunization with chicken type II collagen mutants display a significant reduction in the severity and incidence of arthritis compared to wild-type mice (J:89960)
• 1.5 to 6 hours after lipopolysaccharide injection mutants do not display an increase in core body temperature unlike wild-type mice (J:90980)

homeostasis/metabolism
• prostaglandin E2 levels are significantly reduced in null mice compared to wild-type





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory